Delirium is a common, serious, and often under-recognised complication for people living with cancer, particularly those who are older, frail, or receiving intensive treatments. It is associated with significant distress for patients and families, poorer clinical outcomes, prolonged hospitalisation, and increased mortality. This webinar will explore delirium in people with cancer across the care continuum, from acute treatment through to palliative and end-of-life care. Drawing on current evidence and clinical practice, the session will examine risk factors specific to cancer populations, common precipitating causes, and the impact of delirium on patients, families, and healthcare teams. Practical, person-centred strategies for delirium prevention, early recognition, and management will be discussed, with attention to interdisciplinary roles and communication.

Learning Objectives

  • Describe the prevalence, risk factors, and impact of delirium in people with cancer.
  • Identify strategies for delirium prevention and early recognition in oncology settings.
  • Apply evidence-based approaches to the management of delirium in people with cancer.
  • Reflect on the implications of delirium for patients, families, and health services.